As the Washington PDAB finalizes policies for its drug review process, the EACH Coalition submitted comments to the board emphasizing the importance of keeping patient perspective and impact centered throughout the process.
The letter outlined the potential unintended consequences of cost reviews and upper payment limits (UPLs) and the special considerations necessary for patients with chronic conditions.